Tuesday 18 January 2022

Breakthrough SARS-CoV-2 infection following COVID-19 vaccination in patients with cancer

 Research conducted by the COVID-19 and Cancer Consortium, the results of which were recently published in the Annals of Oncology maintains that cancer patients who contract COVID-19 despite being vaccinated "remain susceptible to severe outcomes."  Dr. Toni K. Choueri of the Department of Medical Oncology at the Dana-Farber Cancer Institute in Boston, emphasizes that "vaccination of close contacts, masking, boosters, and social distancing are needed to protect patients with cancer", particularly if cancer patients come into contact with members of the public that are unvaccinated. 

Click here to read more about this study, believed to be the first to evaluate clinical characteristics and outcomes of cancer patients being infected by COVID-19 after vaccination.    

Source mentioned: Schmidt AL, Labaki C, Hsu C-Y, et al. COVID-19 vaccination and breakthrough infections in patients with cancer. Annals of Oncology; Published online 24 December 2021. DOI: https://doi.org/10.1016/j.annonc.2021.12.006

No comments:

Post a Comment